急性呼吸窘迫综合征的人口学特征、治疗与结局:FORECAST研究
该前瞻性队列研究纳入日本34家医院急诊与重症科收治的166例符合AECC急性肺损伤标准的成人患者,其中157例(94.6%)同时满足柏林定义。AECC急性肺损伤患者中PaO2/FIO2≤100者占39.2%,接受有创正压通气者占92.2%,住院死亡率为38.0%;柏林定义ARDS患者对应比例分别为38.9%、96.8%、37.6%。肺部浸润面积与结局独立相关,低-中潮气量通气在IPPV患者中占75%,糖皮质激素使用率54%且与死亡率呈正相关。
要点
- 166例符合AECC急性肺损伤标准的成人中,157例(94.6%)同时满足柏林定义。
- AECC急性肺损伤患者住院死亡率为38.0%,柏林定义ARDS患者为37.6%。
- AECC急性肺损伤患者中PaO2/FIO2≤100者占39.2%,柏林定义ARDS患者占38.9%。
- 接受IPPV的患者中,低-中潮气量通气占75%;糖皮质激素使用率为54%,且与死亡率呈正相关。
- 肺部浸润面积与ARDS结局独立相关。
适用人群与场景
- 成人患者,经急诊和重症科收治入住ICU,且符合AECC急性肺损伤标准。
诊断标准与关键阈值
- 纳入标准为符合美国-欧洲共识会议(AECC)急性肺损伤(ALI)标准;同时评估是否满足柏林定义。
处置流程与药物剂量
- 接受有创正压通气(IPPV)的患者中,75%实施了低-中潮气量通气。
- 54%的患者使用了糖皮质激素。
研究设计与关键结果
- 前瞻性队列研究,纳入日本34家医院的166例符合AECC急性肺损伤标准的成人患者,其中157例(94.6%)满足柏林定义。
- AECC急性肺损伤患者中PaO2/FIO2≤100者占39.2%,接受IPPV者占92.2%,住院死亡率为38.0%;柏林定义ARDS患者对应为38.9%、96.8%、37.6%。
- 接受IPPV的患者中低-中潮气量通气占75%;糖皮质激素使用率为54%,且与死亡率呈正相关。
- 肺部浸润面积与ARDS结局独立相关。
证据类型、等级与局限
- 证据类型:前瞻性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 该研究提示日本ARDS管理特征为糖皮质激素使用率高(54%),且糖皮质激素使用与死亡率呈正相关。
- 低-中潮气量通气在IPPV患者中占75%,肺部浸润面积与结局独立相关。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Acute respiratory distress syndrome (ARDS) remains a major cause of death. Epidemiology should be continually examined to refine therapeutic strategies for ARDS. We aimed to elucidate demographics, treatments, and outcomes of ARDS in Japan.
METHODS: This is a prospective cohort study for ARDS. We included adult patients admitted to intensive care units through emergency and critical care departments who satisfied the American-European Consensus Conference (AECC) acute lung injury (ALI) criteria. In addition, the fulfillment of the Berlin definition was assessed. Logistic regression analyses were used to examine the association of independent variables with outcomes.
RESULTS: Our study included 166 patients with AECC ALI from 34 hospitals in Japan; among them, 157 (94.6%) fulfilled the Berlin definition. The proportion of patients with PaO2/FIO2 ≤ 100, patients under invasive positive pressure ventilation (IPPV), and in-hospital mortality was 39.2%, 92.2%, and 38.0% for patients with AECC ALI and 38.9%, 96.8%, and 37.6% for patients with Berlin ARDS, respectively. The area of lung infiltration was independently associated with outcomes of ARDS. Low-mid-tidal volume ventilation was performed in 75% of patients under IPPV. Glucocorticoid use was observed in 54% patients, and it was positively associated with mortality.
CONCLUSIONS: Our study included a greater percentage of patients with ARDS with high severity and found that the overall mortality was 38%. The management of ARDS in Japan was characterized by high the utilization rate of glucocorticoids, which was positively associated with mortality.
参考来源
- Fujishima S, Gando S, Saitoh D, et al. Demographics, Treatments, and Outcomes of Acute Respiratory Distress Syndrome: the Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis, and Trauma (FORECAST) Study. Shock. 2020. PMID: 31348148. doi:10.1097/SHK.0000000000001416
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。